|
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
Food and Drug Administration
1401 Rockville Pike
Rockville MD 20852-1448
February 21, 2006
Our STN: BL 103475/5100
GlaxoSmithKline Biologicals
Attn: Ms. Judith Magner
2301 Renaissance Boulevard
P.O. Box 61540
King of Prussia, PA 19406-2772
Dear Ms. Magner:
We have approved your request to supplement your biologics license application for
Hepatitis A Vaccine Inactivated to include the package insert labeling changes regarding geriatric use.
We will include information contained in the above-referenced supplement in your biologics license application file.
Please submit all final printed labeling at the time of use and include implementation information on FDA Form 356h. Please provide a PDF-format electronic copy as well as one original paper copy.
Sincerely yours,
--- signature ---
Karen L. Goldenthal, M.D.
Director
Division of Vaccines and Related Products Applications
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research
|
